Antibody‐dependent complement activity is associated not only with autoimmune morbidity,
but also with antitumor efficacy. In infectious disease, both recombinant monoclonal …

The scale and scope of the global epidemic, coupled to challenges with traditional vaccine
development approaches, point toward a need for novel methodologies for HIV vaccine …

Deep learning has led to incredible breakthroughs in areas of research, from self-driving
vehicles to solutions, to formal mathematical proofs. In the biomedical sciences, however, the …

Phagocytosis can be induced via the engagement of Fcγ receptors by antibody-opsonized
material. Furthermore, the efficiency of antibody-induced effector functions has been shown to …

The human phase 2B RV144 ALVAC-HIV vCP1521/AIDSVAX B/E vaccine trial, held in
Thailand, resulted in an estimated 31.2% efficacy against HIV infection. By contrast, vaccination …

While the induction of a neutralizing antibody response against HIV remains a daunting goal,
data from both natural infection and vaccine-induced immune responses suggest that it …

… Ackerman,7 M. Juliana McElrath,4 Hanneke Schuitemaker,8 Maria G. Pau,8 Lindsey R. …
The THP-1 phagocytosis assay was performed as previously described (Ackerman et …

Preclinical studies of viral vector–based HIV-1 vaccine candidates have previously shown
partial protection against neutralization-resistant virus challenges in rhesus monkeys. In this …

Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as
these individuals develop HIV-specific immunity able to persistently suppress viremia. …

Heterologous prime-boost immunization strategies have the potential to augment COVID-19
vaccine efficacy. We longitudinally profiled severe acute respiratory syndrome coronavirus …